Increased synaptophysin is involved in inflammation-induced heat hyperalgesia mediated by cyclin-dependent kinase 5 in rats.
Mechanisms associated with cyclin-dependent kinase 5 (Cdk5)-mediated heat hyperalgesia induced by inflammation remain undefined. This study was designed to examine whether Cdk5 mediates heat hyperalgesia resulting from peripheral injection of complete Freund's adjuvant (CFA) in the spinal dorsal horns of rats by interacting with synaptophysin, a well known membrane protein mediating the endocytosis-exocytosis cycle of synaptic vesicles as a molecular marker associated with presynaptic vesicle membranes. The role of Cdk5 in mediating synaptophysin was examined through the combined use of behavioral approaches, imaging studies, and immunoprecipitation following CFA-induced inflammatory pain. Results showed that Cdk5 colocalized with both synaptophysin and soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors (SNAREs) consisting of VAMP-2, SNAP-25, and syntaxin 1A in spinal dorsal horn of rats. Increased synaptophysin expression of spinal cord horn neurons post intraplantar injection of CFA coincided with increased duration of heat hyperalgesia lasting from 6 h to 3 d. Intrathecal administration of roscovitine, a Cdk5 specific inhibitor, significantly depressed synaptophysin expression during peak heat hyperalgesia and heat hyperalgesia induced by peripheral injection of CFA. Data presented in this report indicated that calpain activity was transiently upregulated 6 h post CFA-treatment despite previous reports suggesting that calpain was capable of cleaving p35 into p25. Results from previous studies obtained by other laboratories demonstrated that significant changes in p35 expression levels within spinal cord horn neurons were not observed in the CFA-treated inflammatory pain model although significant upregulation of Cdk5 kinase was observed between 2 h to 7 d. Therefore, generation of p25 occurred in a calpain-independent fashion in a CFA-treated inflammatory pain model. Our results demonstrated that increased synaptophysin levels were involved in heat hyperalgesia mediated by Cdk5 in spinal cord dorsal horns of CFA-treated rats, suggesting that inhibiting abnormal activation of Cdk5-synaptophysin may present a novel target for diminishing inflammatory pain.
Department of Anesthesiology Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, PR China.
Hong-Hai
HH
Zhang
Xiao-Qin
XQ
Zhang
Wen-Yuan
WY
Wang
Qing-Sheng
QS
Xue
Han
H
Lu
Jin-Lu
JL
Huang
Ting
T
Gui
Bu-Wei
BW
Yu
D000818:Animals; D015153:Blotting, Western; D051360:Cyclin-Dependent Kinase 5 / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D005620:Freund's Adjuvant / Q000627:therapeutic use; D006930:Hyperalgesia / Q000378:metabolism*; D047468:Immunoprecipitation; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology*; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D016708:Synaptophysin / Q000378:metabolism*; D050988:Vesicle-Associated Membrane Protein 2 / Q000378:metabolism
D016708:Synaptophysin; D050988:Vesicle-Associated Membrane Protein 2; D005620:Freund's Adjuvant; D051360:Cyclin-Dependent Kinase 5